With an oversubscribed trading debut now in the books, Veradermics—developing an oral version of the molecule behind ...

Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both headed to the Nasdaq this ...

The board of NSE approved undertaking the IPO through a pure offer for sale (OFS) by existing shareholders. The IPO will ...

InCred Holdings has received SEBI approval to raise funds via an IPO, with an expected size of ₹3,000-4,000 crore. The Mumbai-based company offers diverse financial services, including lending and ...

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to ...

Arko Corp., which operates convenience stores under its subsidiary GPM Investments LLC, said Tuesday that its subsidiary, ...

For U.S. initial public offerings, 2026 is starting out as a slow burn, with 24 IPOs filed so far, down 11.1% from the same period in 2025, according to Renaissance Capital.

Learn how to evaluate new IPOs, understand valuation methods, and decide if you should invest. Key questions can help you assess potential stocks.

NSE's board approves IPO plans via offer-for-sale, reconstituting a committee to oversee the long-awaited listing process.

The highly anticipated SpaceX IPO appears likely to happen in 2026, and a new report says the offering could be timed to two ...

In the biggest test for initial public offerings so far this year, Bay Area companies had an uneven week that highlights the ...

Discover what "freed up" means in IPOs and investing, how it works for underwriters and insiders, and the process before shares can be traded freely on the market.